The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
The role of pro- and anti- inflammatory cytokines in the pathogenesis of obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? Source: Eur Respir J 2008; 31: 1381-1382 Year: 2008
Selective activation of pro-inflammatory cytokines in obstructive sleep apnoea syndrome and impact of CPAP Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007
Could obstructive sleep apnea syndrome be a component of metabolic syndrome? Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006
Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea Source: International Congress 2015 – Obstructive sleep apnoea in adults and children Year: 2015
The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli? Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II Year: 2011
The role of angiogenesis in obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
The role of hyaluronan metabolism in obstructive sleep apnoea Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020
Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? Source: Eur Respir J 2012; 39: 1547-1549 Year: 2012
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Obstructive sleep apnea syndrome is an independent risk factor for progression of chronic kidney disease: A new link? Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Does obstructive sleep apnoea predispose to reduced renal function? Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010